Skip to content Skip to footer
Constantiam Biosciences
Constantiam Biosciences
Constantiam Biosciences
Close
Rarescan Logo Rarescan logo

Challenges in Rare Disease

The majority of people living with rare diseases remain undiagnosed, exacting an enormous toll on patients and their families, and limiting the pool of patients for newly-developed drugs. Genetic testing plays a pivotal role in the diagnosis of rare diseases, where a patient’s variant must be classified as pathogenic for them to be eligible for treatment or trial enrollment. Population data are often lacking for rare diseases, complicating variant classification and restricting the market for new and existing therapeutics.

 

The RareScan Platform

Constantiam’s RareScan enables more patients to receive a conclusive diagnosis, unlocking lifesaving treatment options. RareScan provides evidence to classify VUS and define patient populations for rare disease therapeutics through innovative application of massively-multiplexed cellular assays and Bayesian generative modeling. This comprehensive approach ensures more variants can be accurately classified, facilitating better diagnoses and expanding the pool of eligible patients for clinical trials and therapeutic interventions.

Contact Us
Info Box

Expanded Patient Population

RareScan significantly improves the ability to classify variants, accelerating diagnoses and expanding the reach of new and existing drugs.

Info Box

Pre-Approval Risk Mitigation

RareScan enables the enrollment of patients who are likely to respond to a therapeutic agent, thereby increasing success rate and mitigating unnecessary risks associated with clinical trials.

Info Box

Efficient Data Collection

RareScan eliminates the need for additional overhead or hiring. We collaborate with your team to leverage their disease-specific expertise, ensuring efficient and effective data collection.

Info Box

Pre-Approval Risk Mitigation

RareScan enables the enrollment of patients who are likely to respond to a therapeutic agent, thereby increasing success rate and mitigating unnecessary risks associated with clinical trials.

Info Box

Efficient Data Collection

RareScan eliminates the need for additional overhead or hiring. We collaborate with your team to leverage their disease-specific expertise, ensuring efficient and effective data collection.